Olivirex for Small Intestinal Bacterial Overgrowth

N/A

Waitlist Available

Research Sponsored by Integrative Skin Science and Research

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 14 weeks

Awards & highlights

No Placebo-Only Group

Summary

This trial is testing a plant-based mixture taken by mouth to help people with small intestinal bacterial overgrowth (SIBO). SIBO happens when there are too many bacteria in the small intestine. The mixture aims to reduce these bacteria and improve gut and skin health.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 14 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~14 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 14 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Lactulose Breath Test

Secondary study objectives

Gut Microbiome Changes

Other study objectives

Facial Assessment for Redness

Safety Assessment for GI Distress

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Intervention GroupExperimental Treatment3 Interventions

Participants will be taking one liquid tincture orally per day as well as 2 capsules orally at night. At week 10, non-responders will take another supplement consisting of 2 capsules orally along with the liquid tincture until week 14.

Do I qualify?Apply below to find out